Patients with Chronic Lymphocytic Leukemia Carrying t(14;19) Display a Distinctive Transcriptomic Profile and Adverse Outcome, Which Might be Overcome Continuous Therapy with BTK Inhibitors. an Italian Campus CLL and Eric Study

JSON

Visentin A, Gaffo E, Furstenau M, Woyach JA, Baliakas P, Rogers KA, Miller C, Haferlach C, Plevova K, Oscier DG, Davis Z, Nguyen Khac F, Roncaglia E, Rigolin GM, Athanasiadou A, Baran-Marszak F, Valiente A, Terol MJ, Abrisqueta P, Espinet B, Puiggros A, Martines A, Bonaldi L, Mauro FR, Scarfo L, Chatzikonstantinou T, Tausch E, Kreuzer KA, Kater AP, Bosch F, Doubek M, Panayiotidis P, Kalashnikova O, Frezzato F, Facco M, Ruocco V, Buratin A, Orsi S, Cellini A, Angotzi F, Cavarretta CA, Zatta I, Serafin A, Foa R, Eichhorst BF, Cuneo A, Stamatopoulos K, Ghia P, Bortoluzzi S, Trentin L

Blood 142 (Supplement 1) 3275-3275 [2023-11-02; online 2023-11-02]

DOI 10.1182/blood-2023-174569

Crossref 10.1182/blood-2023-174569